Amedisys earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed divestiture ...

The U.S. Department of Justice (DOJ) has reportedly rejected Amedisys’ (Nasdaq: AMED) and UnitedHealth Group’s (NYSE: UNH) attempt to divest assets, a ...

UnitedHealth Group and Amedisys have agreed to sell certain home health and hospice locations to BrightSpring Health Services and The Pennant Group to help mitigate antitrust concerns over the ...

For those who have been following the U.S. Department of Justice’s (DOJ) legal battle against UnitedHealth Group (NYSE: UNH) and Amedisys Inc. (NASDAQ: ...

UnitedHealth Group and Amedisys have found buyers for key divestitures aimed at getting their $3.3 billion merger over the finish line, according to new filings. In documents submitted to the ...

The company brought back Chairman and former CEO Stephen Hemsley for the top role, saying Andrew Witty has resigned “for ...

UnitedHealth Group is under federal investigation for possible criminal fraud involving its Medicare program, the Wall Street ...

In addition to those headwinds, UnitedHealth also faces growing scrutiny in Washington, as antitrust regulators challenge its ...

Stephen Hemsley is again leading Minnesota’s largest company as it grapples with financial uncertainties and increasing ...

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the Department of Justice sued to block the deal last year. Amedisys delivers ...

UNH's troubles are piling up, from a fresh DOJ criminal probe and rising costs to leadership shakeups and pulled guidance.